Genenta Science SPA banner

Genenta Science SPA
NASDAQ:GNTA

Watchlist Manager
Genenta Science SPA Logo
Genenta Science SPA
NASDAQ:GNTA
Watchlist
Price: 0.9509 USD -5.85% Market Closed
Market Cap: $18.2m

Genenta Science SPA
Investor Relations

Genenta Science SpA engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. The company is headquartered in Milan, Milano and currently employs 4 full-time employees. The company went IPO on 2021-12-15. The firm focuses on the development of lentivirus-based gene and cell therapies in cancer. The company uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The firm not only operates locally but also is present in global markets, including the United States.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Pierluigi Paracchi
Co-Founder, Chairman & CEO
No Bio Available
Dr. Luigi Naldini M.D., Ph.D.
Co-Founder & Chairman of the Executive Scientific Board
No Bio Available
Dr. Bernard Rudolph Gentner M.D., Ph.D.
Co-Founder & Member of the Executive Scientific Board
No Bio Available
Mr. Richard B. Slansky
Chief Financial Officer
No Bio Available
Dr. Carlo Russo M.D.
Chief Medical Officer & Head of Development
No Bio Available
Dr. Stefania Mazzoleni Ph.D.
Director of Program Development
No Bio Available
Ms. Barbara Regonini
Director of Finance
No Bio Available

Contacts

Address
MILANO
Milan
Via Olgettina 58
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett